About
Basic Data Updated:
4 months agoGlenmark Pharmaceuticals Limited is known for its development, manufacturing, and marketing of pharmaceutical products and API's. With a global presence in over 60 countries, the company has established itself as a leader in the industry. Currently, it operates 18 facilities in six different countries. GPL specializes in providing both branded and generic formulations in therapeutic areas such as dermatology, respiratory, and oncology. Additionally, the company offers a wide range of active pharmaceutical ingredients. In India, Glenmark's manufacturing facilities are strategically located in Nashik, Sholapur, and Pune (all in Maharashtra), Ankleshwar (Gujarat), Bardez (Goa), Indore (Madhya Pradesh), and Solan (Himachal Pradesh). The company was founded in 1977 and is headquartered in Mumb... Read More
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Products or Services related to Glenmark Pharmaceuticals Limited
Baby Skin Care
Natural Hair & Skin Care
Hair Conditioners
Acne Care
Financials of Glenmark Pharmaceuticals Limited
Enhance accessibility to Glenmark Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Glenmark Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Glenmark Pharmaceuticals Limited
Unlock and access historical data on people associated with Glenmark Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
GS
Glenn Saldanha
Managing DirectorAppointment Date: 12-Oct-1998
Status: Current
VM
V Mani CFOAppointment Date: 16-Nov-2017
Status: Current
HK
Harish Kuber Company SecretaryAppointment Date: 02-Feb-2017
Status: Current
Board Members(10)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 21 May 1985 | ₹890.00 Cr | Open |
Bank Of India Creation Date: 29 Jul 2009 | ₹60.00 Cr | Satisfied |
Axis Bank Limited Creation Date: 18 Jun 2009 | ₹75.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glenmark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glenmark Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Glenmark Life Sciences Limited
Active
12 years 10 months Sridhar Gorthi, Glenn Saldanha and 1 more are mutual person
Recent activity within the organization
Annual General Meeting
Glenmark Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Director Appointment
Vijayalakshmi Rajaram Iyer was appointed as a Director was appointed as a Director on 14 Apr 2023 & has been associated with this company since 1 year 16 days .
14 Apr 2023Balance Sheet
Glenmark Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge registered on 23 Sep 2004 via Charge ID 80033325 with State Bank Of India was fully satisfied on 22 Jun 2022.
22 Jun 2022Charges
A charge registered on 09 Jun 2008 via Charge ID 10114486 with Bank Of India was fully satisfied on 05 May 2022.
05 May 2022
Recent News, Updates & Announcement
Glenmark Jiangsu Alphamab and 3D Medicines announce the signing of a License Agreement for KN035.siliconindia 25 Jan 2024
- Introducing Lirafit Indias Affordable Diabetes Medication by Glenmark Pharmaceuticals.
Drug company launches new diabetes medicine in India called Lirafit Its a cheaper version of Liraglutide and helps control blood sugar and heart and kidney health Only available with prescription and costs around Rs 100 Glenmark Pharmaceuticals is proud to offer this affordable option for type 2 diabetes patients.
IndiaMedToday 04 Jan 2024
- Glenmark to market respiratory product in Nordic countries.
Glenmark had entered into a strategic development and licensing agreement with Celon Pharma SA to develop and market a generic version of GlaxoSmithKlines Seretide Accuhaler product FluticasoneSalmeterol dry powder Inhaler in Europe.
PTI 01 Dec 2017
- Glenmark Pharma Gets Approval For Inhaler Product In Nordic Countries.
Business Standard 01 Dec 2017
- Glenmark to market respiratory product in Nordic countries.
Business Line 01 Dec 2017
Frequently asked questions
What is the Incorporation or founding date of Glenmark Pharmaceuticals Limited?
